UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
ISU Abxis’ US partner to start P2b trials of hemophilia B treatment
ISU Abxis said Friday that Catalyst Biosciences, its U.S. partner, has begu...
by Lee Han-soo
|
2019-04-05 16:16
라인
Gemvax & Kael’s wins nod for P3 trial of benign prostatic hyperplasia treatment
Gemvax & Kael said Friday that the Ministry of Food and Drug Safety has app...
by Lee Han-soo
|
2019-04-05 14:49
라인
Handok, CMG apply for P1 trial for anticancer treatment candidate
Handok and CMG Pharmaceutical said they have applied to the Ministry of Foo...
by Lee Han-soo
|
2019-04-05 12:23
라인
Court suspends ministry’s disciplinary action against Dong-A ST
The Seoul Administrative Court Wednesday suspended the Ministry of Health a...
by Lee Han-soo
|
2019-04-04 16:55
라인
Corestem’s Lou Gehrig disease treatment becomes orphan drug in EU
Corestem said Wednesday that NeuroNata-R, its Lou Gehrig's disease ther...
by Lee Han-soo
|
2019-04-04 15:25
라인
Genexine, NeoImmuneTech release 2 clinical trial results at AACR
Genexine and NeoImmuneTech said Thursday that they have presented two poste...
by Lee Han-soo
|
2019-04-04 14:16
라인
GC, Clinigen K.K. ink licensing accord for Hunter syndrome drug
GC said Thursday that it has signed an exclusive licensing agreement to com...
by Lee Han-soo
|
2019-04-04 11:19
라인
Fate of Kolon Life Science hangs on Invossa-K test results
The drug authorities will decide the level of a sanction against Kolon Life...
by Lee Hye-seon
|
2019-04-03 18:14
라인
[Special] MSD Korea makes wrong excuse on external monitoring
After Korea Biomedical Review’s exclusive report revealed that MSD Korea co...
by Jeong Sae-im
|
2019-04-03 16:59
라인
GC releases preclinical trial results for immunotherapy candidate at AACR
GC said Wednesday that it has presented the preclinical trial results of MG...
by Lee Han-soo
|
2019-04-03 14:18
라인
Qurient displays immunotherapy candidate at AACR
Qurient said Wednesday that it held a poster session to present the preclin...
by Lee Han-soo
|
2019-04-03 14:18
라인
Kang becomes new CEO of Abbvie Korea
Abbvie Korea said Monday that it has appointed Kang So-young as its new gen...
by Lee Han-soo
|
2019-04-03 10:50
라인
Lilly’s migraine-preventing therapy becomes orphan drug here
The Ministry of Food and Drug Safety (MFDS) announced Monday that it has gi...
by Lee Han-soo
|
2019-04-02 16:09
라인
‘Paternity testing’ would have prevented Invossa debacle
Kolon Life Science’s mislabeling one of the ingredients of Invossa-K, gene ...
by Jeong Sae-im
|
2019-04-02 15:27
라인
[Special] MSD Korea asks monitoring agents to record talks ‘discreetly’
MSD Korea’s Self-Assurance program initially aimed to ensure legitimacy, tr...
by Jeong Sae-im
|
2019-04-02 14:45
라인
Kolon apologizes for ‘mislabeled’ ingredient in Invossa
Kolon Life Science apologized Monday for “mislabeling” one of its key compo...
by Lee Han-soo
|
2019-04-01 17:35
라인
ST Pharm unveils pre-clinical trial results for HIV treatment
ST Pharm said Monday that it has presented the pre-clinical trial results f...
by Lee Han-soo
|
2019-04-01 15:39
라인
Argatroban raises bleeding risk in pregnant women
The Korean regulator would add a precaution label to argatroban, a treatmen...
by Lee Hye-seon
|
2019-04-01 15:29
라인
Hanmi launches seborrheic dermatitis treatment
Hanmi Pharmaceutical said Monday that it has launched Dupien, a seborrheic ...
by Lee Han-soo
|
2019-04-01 14:24
라인
[Special] Why doctors got upset with MSD Korea’s monitoring program
MSD Korea said it was running the Self-Assurance program to ensure legitima...
by Jeong Sae-im
|
2019-04-01 14:22
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top